New hope for advanced lung cancer patients in pfizer trial
NCT ID NCT07227298
Summary
This study is testing a new drug, PF-08634404, when used alongside other cancer medicines in adults with advanced non-small cell lung cancer that has spread. The main goals are to see if the drug combinations are safe and if they can help control the cancer. The study is in early phases, focusing on safety and initial signs of effectiveness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
BRCR Global Puerto Rico - Hato Rey
RECRUITINGSan Juan, 00917, Puerto Rico
-
Kansai Medical University Hospital
RECRUITINGHirakata, Osaka, 573-1191, Japan
-
Mid Florida Hematology and Oncology Center
RECRUITINGOrange City, Florida, 32763, United States
-
Oncology Associates of Oregon, P.C
RECRUITINGEugene, Oregon, 97401, United States
-
Pan American Center for Oncology Trials, LLC
RECRUITINGSan Juan, 00909, Puerto Rico
Conditions
Explore the condition pages connected to this study.